Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems

被引:99
作者
Aumelas, A. [1 ]
Serrero, A. [1 ]
Durand, A. [1 ]
Dellacherie, E. [1 ]
Leonard, M. [1 ]
机构
[1] Nancy Univ, CNRS, ENSIC, UMR 7568,Lab Chim Phys Macromol, F-54001 Nancy, France
关键词
hydrophobically modified dextran; nanoparticles; emulsion; nanoprecipitation;
D O I
10.1016/j.colsurfb.2007.04.021
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Nanoparticles combining a hydrophobically modified dextran core and a polysaccharide surface coverage were elaborated. Their suitability for applications like drug delivery was evaluated. The selected polysaccharide, dextran, was chemically modified by the covalent attachment of hydrocarbon groups (aliphatic or aromatic) via the formation of ether links. According to the extent of modification, either water-soluble or water-insoluble dextran derivatives were obtained. The latter exhibited solubility in organic solvents like tetrahydroftiran or dichloromethane saturated with water. Water-soluble dextran derivatives were used as polymeric surfactants for the control of nanoparticles surface characteristics. Nanoparticles were prepared either by o/w emulsion or solvent-diffusion methods. The size and surface properties of dextran nanoparticles were correlated to processing conditions. The stability of colloidal suspensions was examined as a function of ionic strength and related to the particle surface characteristics. The redispersability of freeze-dried suspensions without the addition of cryoprotectant was demonstrated. Finally, the degradability of modified dextrans was compared to that of starting dextran, after enzymatic hydrolysis in the presence of dextranase. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:74 / 80
页数:7
相关论文
共 41 条
[1]   Biodegradation and biocompatibility of PLA and PLGA microspheres [J].
Anderson, JM ;
Shive, MS .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) :5-24
[2]  
[Anonymous], [No title captured]
[3]   Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: Influences of surface morphology, length, and type of polysaccharide [J].
Bertholon, Isabelle ;
Vauthier, Christine ;
Labarre, Denis .
PHARMACEUTICAL RESEARCH, 2006, 23 (06) :1313-1323
[4]  
Chauvierre C, 2004, CELL MOL BIOL, V50, P233
[5]   Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery [J].
Cheng, Jianjun ;
Teply, Benjamin A. ;
Sherifi, Ines ;
Sung, Josephine ;
Luther, Gaurav ;
Gu, Frank X. ;
Levy-Nissenbaum, Etgar ;
Radovic-Moreno, Aleksandar F. ;
Langer, Robert ;
Farokhzad, Omid C. .
BIOMATERIALS, 2007, 28 (05) :869-876
[6]   Physicochemical evaluation of PLA nanoparticles stabilized by water-soluble MPEO-PLA block copolymers [J].
Chognot, D ;
Six, JL ;
Leonard, M ;
Bonneaux, F ;
Vigneron, C ;
Dellacherie, E .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2003, 268 (02) :441-447
[7]   Surfactive water-soluble copolymers for the preparation of controlled surface nanoparticles by double emulsion/solvent evaporation [J].
Chognot, David ;
Leonard, Michele ;
Six, Jean-Luc ;
Dellacherie, Edith .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2006, 51 (01) :86-92
[8]   Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments [J].
Coombes, AGA ;
Tasker, S ;
Lindblad, M ;
Holmgren, J ;
Hoste, K ;
Toncheva, V ;
Schacht, E ;
Davies, MC ;
Illum, L ;
Davis, SS .
BIOMATERIALS, 1997, 18 (17) :1153-1161
[9]   Surface modification of polystyrene nanoparticles using dextrans and dextran-POE copolymers: Polymer adsorption and colloidal characterization [J].
De Sousa Delgado, A ;
Leonard, M ;
Dellacherie, E .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2000, 11 (12) :1395-1410
[10]   POLYSTYRENE-POLY(ETHYLENE GLYCOL) (PS-PEG2000) PARTICLES AS MODEL SYSTEMS FOR SITE-SPECIFIC DRUG-DELIVERY .2. THE EFFECT OF PEG SURFACE-DENSITY ON THE IN-VITRO CELL-INTERACTION AND IN-VIVO BIODISTRIBUTION [J].
DUNN, SE ;
BRINDLEY, A ;
DAVIS, SS ;
DAVIES, MC ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (07) :1016-1022